Clinical study of efficacy and safety of Chung A Won in Women’s patients with osteoporosis

Not Applicable

Recruiting

• Conditions: Diseases of the musculo-skeletal system and connective tissue

• Registration Number: KCT0000594
• Lead Sponsor: Cheonan Korean Medicine Hospital of Daejeon University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 106

Inclusion Criteria

Female more than 50 years old in osteoporosis

Exclusion Criteria

1)Wash out peroid: using agents more than 3 months against osteoporosis
2)Subject who takes drugs that may affect the clinical trials (Corticosteroids, anticonvulsants, tranquilizers, antidepressants, hypnotic, diuretic)
3)Subject who has a chronic liver disease, thyroid disease and chronic renal disease
4)Subject who is chronic alcoholics and undernourished
5)Other conditions were not suitable in study : Severe physical defects mental defects
6)Pregnant woman
7)Subject who is not calibrated hypercalcemia/hypocalcemia
8) Secondary osteoporosis : Subject who takes drugs(Glucocorticoid, Diabetes Medications)
9) Subject who has 60% more fracture risk in FRAX(WHO fracture risk assessment tool)

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The change of T-score of bone mineral density(QCT)

Secondary Outcome Measures

Name	Time	Method
The change of T-score;The change of osteoporosis-related indicators of blood tests;The change of ODI(Oswestry Disability Index) ;The change of QVAS(Quardruple Visual Analog Scale);The change of kupperman index;The change of shin-huh symptoms;The change of quality of life using SF-36